Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / ISHARES BIOTECH
-
Number of holders
-
407
-
Total 13F shares, excl. options
-
14,816,870
-
Shares change
-
-1,587,339
-
Total reported value, excl. options
-
$3,854,656,469
-
Value change
-
-$440,823,854
-
Put/Call ratio
-
147%
-
Number of buys
-
181
-
Number of sells
-
210
-
Price
-
$260.81
Institutional Holders of ISHARES TR - ISHARES BIOTECH (IBB) as of Q1 2016
As of 31 Mar 2016 ISHARES TR - ISHARES BIOTECH (IBB) had 555 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 14,816,870 shares of stock of the company.
Largest 10 holders included BANK OF AMERICA CORP /DE/, GOLDMAN SACHS GROUP INC, CITIGROUP INC, MORGAN STANLEY, BNP PARIBAS ARBITRAGE, SA, UBS Group AG, LPL Financial LLC, JANE STREET GROUP, LLC, COMMERCE BANK, and TWO SIGMA ADVISERS, LP.
This table shows 555 institutional shareholders of the security as of 31 Mar 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.